Anhui Huangshan Capsule Co., Ltd. (SHE:002817)
China · Delayed Price · Currency is CNY 8.06
+0.13 (1.64%)
Apr 10, 2026, 3:04 PM CST
Anhui Huangshan Capsule Revenue
In the year 2025, Anhui Huangshan Capsule had annual revenue of 460.42M CNY, down -2.76%. Anhui Huangshan Capsule had revenue of 116.34M in the quarter ending December 31, 2025, a decrease of -8.39%.
Revenue
460.42M
Revenue Growth
-2.76%
P/S Ratio
5.15
Revenue / Employee
676.10K
Employees
681
Market Cap
2.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 460.42M | -13.06M | -2.76% |
| Dec 31, 2024 | 473.48M | 10.71M | 2.31% |
| Jan 1, 2024 | 462.77M | 34.45M | 8.04% |
| Jan 1, 2023 | 428.32M | 48.43M | 12.75% |
| Dec 31, 2021 | 379.89M | 60.46M | 18.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hainan Huluwa Pharmaceutical Group | 1.06B |
| Enwei Pharmaceutical | 888.64M |
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD | 886.96M |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.26M |
| Chengdu huasun technology group Inc. , LTD. | 545.50M |
| Shaanxi Kanghui Pharmaceutical | 513.23M |
| Zhejiang Shapuaisi Pharmaceutical | 475.19M |
| Guhan Pharmaceutical Group | 337.67M |